NO20080464L - Terapeutisk kombinasjon omfattende en NMDA-reseptorhemmer og en narkotisk analgesisk substans - Google Patents

Terapeutisk kombinasjon omfattende en NMDA-reseptorhemmer og en narkotisk analgesisk substans

Info

Publication number
NO20080464L
NO20080464L NO20080464A NO20080464A NO20080464L NO 20080464 L NO20080464 L NO 20080464L NO 20080464 A NO20080464 A NO 20080464A NO 20080464 A NO20080464 A NO 20080464A NO 20080464 L NO20080464 L NO 20080464L
Authority
NO
Norway
Prior art keywords
narcotic analgesic
nmda receptor
receptor inhibitor
substance
analgesic substance
Prior art date
Application number
NO20080464A
Other languages
English (en)
Norwegian (no)
Inventor
Paolo Chiesi
Gino Villetti
Original Assignee
Chiesi Farma Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chiesi Farma Spa filed Critical Chiesi Farma Spa
Publication of NO20080464L publication Critical patent/NO20080464L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4468—Non condensed piperidines, e.g. piperocaine having a nitrogen directly attached in position 4, e.g. clebopride, fentanyl
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/485—Morphinan derivatives, e.g. morphine, codeine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Emergency Medicine (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Rheumatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NO20080464A 2005-07-28 2008-01-25 Terapeutisk kombinasjon omfattende en NMDA-reseptorhemmer og en narkotisk analgesisk substans NO20080464L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP05016391 2005-07-28
PCT/EP2006/007049 WO2007017058A1 (en) 2005-07-28 2006-07-18 Therapeutic combination comprising a nmda receptors blocker and a narcotic analgesic substance

Publications (1)

Publication Number Publication Date
NO20080464L true NO20080464L (no) 2008-02-28

Family

ID=37114513

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20080464A NO20080464L (no) 2005-07-28 2008-01-25 Terapeutisk kombinasjon omfattende en NMDA-reseptorhemmer og en narkotisk analgesisk substans

Country Status (11)

Country Link
US (1) US20080287480A1 (pt)
EP (1) EP1909781A1 (pt)
JP (1) JP2009502828A (pt)
AU (1) AU2006278933A1 (pt)
BR (1) BRPI0613281A2 (pt)
CA (1) CA2616659A1 (pt)
MX (1) MX2008000780A (pt)
NO (1) NO20080464L (pt)
NZ (1) NZ565416A (pt)
WO (1) WO2007017058A1 (pt)
ZA (1) ZA200800780B (pt)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CU20190114A7 (es) * 2019-12-26 2021-08-06 Centro De Investig Y Desarrollo De Medicamentos Cidem Combinación para simultáneamente incrementar la eficacia analgésica de la morfina y reducir su dependencia física

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2115792C (en) * 1993-03-05 2005-11-01 David J. Mayer Method for the treatment of pain
PT1321139E (pt) * 2001-12-21 2007-01-31 Chiesi Farma Spa Derivados de 2-indanilamino para a terapêutica da cor crónica

Also Published As

Publication number Publication date
MX2008000780A (es) 2008-02-19
AU2006278933A1 (en) 2007-02-15
BRPI0613281A2 (pt) 2010-12-28
ZA200800780B (en) 2009-05-27
JP2009502828A (ja) 2009-01-29
EP1909781A1 (en) 2008-04-16
NZ565416A (en) 2011-03-31
WO2007017058A1 (en) 2007-02-15
CA2616659A1 (en) 2007-02-15
US20080287480A1 (en) 2008-11-20

Similar Documents

Publication Publication Date Title
WO2008039218A3 (en) Inhibitors of bruton's tyrosine kinase
TW200637547A (en) Compounds and compositions as protein kinase inhibitors
MY144044A (en) Compounds and compositions as protein kinase inhibitors
MX2009006007A (es) Profarmacos y metodos para hacer y usar los mismos.
CA2683786C (en) Use of tapentadol in the treatment of pain and with a reduced incidence of tapentadol-induced side-effects
MX2008000915A (es) Tratamiento con inhibidores de absorcion de colesterol basados en azetidinona y acidos grasos omega-3 y un producto de combinacion de los mismos.
NO20084256L (no) DPP IV inhibitorformuleringer
WO2008148074A3 (en) Inhibitors of mtor and methods of treatment using same
WO2006066008A3 (en) Device and methods for identifying and treating aspirin non-responsive patients
ZA200810124B (en) Pharmaceutical combination comprising 3-(3-dimethyl-amino-1-ethyl-2-methyl-propyl)-phenol and Paracetamol
NO20065936L (no) Sulfonyletylfosfordiamidater for anvendelse ved behandling av cancer.
TW200738228A (en) Neramexane modified release matrix tablet
NO20055173L (no) Farmasoytisk kombinasjonsblanding omfattende modafinil og et annet legemiddel
WO2005039486A3 (en) Compounds and compositions as protein kinase inhibitors
EA200970353A1 (ru) Комбинированное лекарственное средство
MX2007013301A (es) Agente profilactico/terapeutico para la anormalidades del metabolismo del azucar/lipidos.
EA200901062A1 (ru) Использование ингибиторов растворимой эпоксидгидролазы для предотвращения и лечения метаболического синдрома и соответствующих расстройств
DK1611252T3 (da) In vitro-fremgangsmåde til påvisning af overgangscelle-karcinom i blæren
NO20080464L (no) Terapeutisk kombinasjon omfattende en NMDA-reseptorhemmer og en narkotisk analgesisk substans
WO2007044325A3 (en) Apoe4 domain interaction inhibitors and methods of use thereof
WO2007047205A3 (en) Enzyme inhibitors of pai-1
MX2007007206A (es) Uso de un agonista 5-ht6 para el tratamiento y la prevencion de trastornos neurodegenerativos.
WO2005060996A3 (en) Method of altering the pka type i signalling pathway
TW200633720A (en) Medicinal composition for diabetic
WO2006103118A3 (en) Therapeutic use of scin, a staphylococcal complement inhibitor in inflammatory diseases

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application